- < Nephrology
Research Code Sharing in Support of Gold Standard Science
By afschroeder • January 15, 2026
Klonoff DC, Espinoza J, Mader JK, Heinemann L, Cobelli C, Kerr D, Kovatchev B, Najafi B, Prahalad P, Zheng Y, Shao MM, Scheideman AF, DuNova AY, Kohn M, Umpierrez GE, Wong TY, Abdel Malek A, Agus MSD, Ahn DT, AlSaad R, Al-Sofiani ME, Armstrong D, Arnold MA, Bee YM, Bequette BW, Bellazzi R, Cengiz E, Chase JG, Chen H, Chen JY, Cichosz SL, Cinar A, Clements MA, Close KL, Cuadros J, Contreras I, Datta G, Dhatariya K, Doyle FJ 3rd, Drincic A, Facchinetti A, Fleming GA, Foreman J, Gabbay MAL, Gutierrez-Osuna R, Healey E, Hoang TD, Jacobs PG, Kulzer B, La Belle J, Lee AY, Lee CS, Lee WA, Liepmann D, Maahs D, Mathioudakis N, Meo SA, Metwally AA, Misra S, Mohan V, Moon SJ, Raeder H, Rhee C, Rhee EJ, Scheinker D, Shah VN, Sheng B, Snyder MP, Sode K, Spanakis EK, Svensson J, Vaswani N, Vareth M, Vehi J, Wallia A, Waki K, Wang T, Williams E Jr, Wolf RM, Wong JC, Yeshiwas S, Zilbermint M, Shah SN. Research Code Sharing in Support of Gold Standard Science. J Diabetes Sci Technol. 2026 Jan 14:19322968251391819. doi: 10.1177/19322968251391819. Epub ahead of print. PMID: 41532590.
Related Posts
Laxamana TD, Fervenza FC, Glassock RJ, Zand L. A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA[...]
Giri K, Glassock RJ, Fervenza FC. Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab? Kidney Int Rep. 2026 Mar 4;11(4):106416. doi: 10.1016/j.ekir.2026.106416.[...]
Oliva-Damaso N, Martinez-Palma L, Oliva-Damaso E, Payan J, Glassock RJ. Discharge criteria from nephrology follow-up back to primary care in modern-era CKD: a review of[...]
